Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients

/Home/Lung Cancer Healthcare and Treatment/Lung Cancer Clinical Trials/Small Cell Lung Cancer Clinical Trials

Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
This study is currently recruiting participants.
Verified by University Hospital, Strasbourg, France, January 2009
Sponsored by: University Hospital, Strasbourg, France

Information provided by: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT00213798

Purpose
The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.



Condition Intervention
Non-Small Cell Lung Carcinoma
Small Cell Lung Cancer
Procedure: Biopsy samples




MedlinePlus related topics: Cancer Lung Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Screening, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title: Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.


Further study details as provided by University Hospital, Strasbourg, France:


Estimated Enrollment: 200
Study Start Date: December 2003

Eligibility


Ages Eligible for Study: 18 Years and older
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No

Criteria
Inclusion Criteria:

Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis.
No lung instability.
Individuals give all informed consent
Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00213798


Contacts
Contact: Michèle Beau-Faller, MD michele.faller@chru-strasbourg.fr


Locations
France
Service de Pneumologie, Hôpital de Hautepierre Recruiting
STRASBOURG, France, 67098
Contact: Michèle BEAU-FALLER, MD 33.3.88.12.71.79 Michele.Faller@chru-strasbourg.fr
Principal Investigator: Michèle BEAU-FALLER, MD
Sub-Investigator: Romain KESSLER, MD
Sub-Investigator: Emmanuel WEITZENBLUM, MD
Service de Pneumologie, Hôpital Civil Recruiting
STRASBOURG, France, 67091
Contact: Gabrielle PAULI, MD 33.3.88.11.62.23 Gabrielle.Pauli@chru-strasbourg.fr
Sub-Investigator: Elisabeth QUOIX, MD
Sub-Investigator: Gabrielle PAULI, MD
Principal Investigator: Michèle Beau-Faller, MD
Service de Chirurgie Thoracique, Hôpital Civil Recruiting
Strasbourg, France, 67091
Contact: Michèle Beau-Faller, MD michele.faller@chru-strasbourg.fr
Sub-Investigator: Jean-Marie WIHLM, MD
Sub-Investigator: Gilbert MASSARD, MD
Sub-Investigator: Xavier-Pierre DUCROCQ, MD
Sub-Investigator: Valérie HAMMERER, MD
Sub-Investigator: Carine METZ FAVRE, MD
Sub-Investigator: Mircea-Dan VASILESCU, MD
Service de Pneumologie, Hôpital Lyautey Recruiting
Strasbourg, France, 67000
Contact: Michèle Beau-Faller, MD michele.faller@chru-strasbourg.fr
Sub-Investigator: Anita DIETEMANN, MD
Sub-Investigator: Bertrand MENNECIER, MD

Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Principal Investigator: Michèle BEAU-FALLER, MD Service de Pneumologie, Hôpital de Hautepierre

More Information

Responsible Party: University Hospital, Strasbourg, France ( Emmanuel LAVOUE, Directeur Adjoint )
Study ID Numbers: 2731
Study First Received: September 13, 2005
Last Updated: January 9, 2009
ClinicalTrials.gov Identifier: NCT00213798 [history]
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Strasbourg, France:
Lung cancer
plasma DNA
allelotyping
follow-up
Prospective Study
Non-Small Cell Lung Cancer
Small Cell Lung Cancer



Study placed in the following topic categories:
Thoracic Neoplasms
Non-small cell lung cancer
Carcinoma, Neuroendocrine
Carcinoma
Neuroendocrine Tumors
Carcinoma, Small Cell
Neuroectodermal Tumors
Respiratory Tract Diseases
Lung Neoplasms
Lung Diseases
Neoplasms, Germ Cell and Embryonal
Neuroepithelioma
Adenocarcinoma
Carcinoma, Non-Small-Cell Lung
Neoplasms, Glandular and Epithelial



Additional relevant MeSH terms:
Neoplasms by Site
Respiratory Tract Neoplasms
Neoplasms, Nerve Tissue
Neoplasms
Neoplasms by Histologic Type



ClinicalTrials.gov processed this record on February 10, 2009


Back to top of Main Content


U.S. National Library of Medicine, Contact Help Desk
U.S. National Institutes of Health, U.S. Department of Health & Human Services,
USA.gov, Copyright, Privacy, Accessibility, Freedom of Information Act